CMC & Development Strategy
Phase-appropriate approaches to drug substance, drug product, analytical sciences, clinical supply, regulatory submissions, and commercialization.
FROM SCIENCE TO IMPACT
Scientific depth.
Strategic direction.
Independent executive-level guidance across pharmaceutical development, CMC strategy, manufacturing, and technical operations.
Csanad M. Varga, PhDFounder & Principal | Alpine Vector Consulting LLC
20+ yearsPharmaceutical industry leadership
Discovery to commercialEnd-to-end development experience
MIT PhDBiological Engineering
ABOUT
Experience at the intersection of science, strategy, and execution.
Csani is a pharmaceutical executive with more than two decades of experience guiding the development, manufacturing, and commercialization of innovative therapeutics. His career spans hands-on scientific research, the creation and leadership of multidisciplinary development organizations, and senior executive oversight of global technical operations and quality.
He joined Blueprint Medicines as its sole CMC professional when the company had just 52 employees, and helped scale its technical capabilities as the company grew. He went on to lead a global Technical Operations and Quality organization of more than 100 people as Senior Vice President. His work included CMC strategy and execution across discovery, clinical development, regulatory approvals, commercial manufacturing, global supply chain, and quality.
Through Alpine Vector Consulting, he brings that combination of scientific rigor and executive perspective to focused advisory engagements.
ADVISORY EXPERTISE
Focused counsel for complex scientific and business decisions.
Selective engagements where technical depth and seasoned executive judgment can help advance a program, asset, or organization.
Technical Operations & Manufacturing
Operating models, outsourced development and manufacturing, CDMO partnerships, supply networks, process transfer, and lifecycle management.
Portfolio & Asset Transitions
Technical evaluation and planning for strategic partnerships, licensing, and transitions of development-stage and commercial assets.
Specialized Technical Matters
Independent scientific and formulation expertise, technical assessment, and support in complex development and intellectual property matters.
SELECTED EXPERIENCE
Built in the laboratory. Proven in the boardroom.
Blueprint Medicines
Progressed through senior leadership roles from Senior Director of Pharmaceutical Sciences to Senior Vice President, Technical Operations and Quality.
- Joined as Blueprint’s sole CMC professional when the company had 52 employees, ultimately leading a global Technical Operations and Quality organization of more than 100 people.
- Contributed to the development and commercial approvals of AYVAKIT® and GAVRETO®.
- Oversaw CMC programs, outsourced manufacturing strategy, global technical operations, quality, and supply chain.
Takeda / Millennium Pharmaceuticals
Held scientific and departmental leadership roles in formulation sciences, pharmaceutical profiling, and biopharmaceutics.
- Led teams responsible for sterile product formulation and physicochemical characterization.
- Supported manufacturing transfer, regulatory submissions, and late-stage CMC strategy.
- Named inventor on published pharmaceutical patent applications.
Scientific foundation
PhD research in quantitative gene delivery mechanisms at MIT, complemented by peer-reviewed publications and work spanning biotechnology and pharmaceutical development.
CONNECT
Let's discuss the challenge ahead.
For inquiries about independent strategic, scientific, or technical advisory engagements, please get in touch.
[email protected]Based in Massachusetts · Serving pharmaceutical and biotechnology organizations